,

Implications of trial results: the potentially misleading notions of number needed to treat and average duration of life gained.

, , и .
Lancet, 356 (9243): 1757-9 (ноября 2000)2825<m:linebreak></m:linebreak>NNT.
DOI: 10.1016/S0140-6736(00)03215-3

Аннотация

Consider a physician advising a patient to start antihypertensive treatment. He has the unenviable task of presenting often conflicting trial data in a comprehensible manner. He must justly represent the known risks and benefits such that his patient can make a reasonably Informed choice. Should the physician cite the number needed to treat or the average duration of life gained to clarify his explanations?

тэги

Пользователи данного ресурса

  • @jepcastel

Комментарии и рецензии